Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Nørskov, Kristina Holmegaard ; Fridthjof, Katrine ; Kampmann, Peter ; Dünweber, Anne ; Andersen, Christen Lykkegaard ; Renaberg, Toni ; Schöllkopf, Claudia ; Ahmad, Syed Azhar ; Schou, Katrine ; Jensen, Cecilie Fremming ; Møller, Peter ; Lundholm, Birgitte Wolf ; Marcher, Claus ; Jepsen, Lene ; Ørntoft, Anne Katrine ; Ommen, Hans Beier ; Andersen, Lotte ; Behrentzs, Anni ; Hasselgren, Connie Fruergaard ; Severinsen, Marianne ; Grand, Mia Klinten ; Jarden, Mary ; Møller, Tom ; Kjeldsen, Lars. / A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia. I: Leukemia Research. 2022 ; Bind 112.

Bibtex

@article{c9203fb7ff5847058653dee1f8190454,
title = "A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia",
abstract = "Technological advances have made it possible to offer home-based chemotherapy to patients without health care professionals being present. Prior studies on effects of home-based treatment lack inclusion of patients with hematologic malignancies. We present data from a multicenter single-arm feasibility and safety study of home-based intensive chemotherapy in patients with newly diagnosed acute myeloid leukemia and their quality of life and psychological wellbeing. This national study included patients from six sites in Denmark who received intensive chemotherapy on programmed CADD Solis infusion pumps through a central venous catheter and were also managed as outpatients during treatment-induced pancytopenia. Data are presented from 104 patients, receiving 272 treatments with 1.096 (mean 4.57, SD 3.0) home infusion days out of 1.644 treatment days (67 %). Sixty-two of 168 (36.9 %) reinduction and consolidation treatment cycles ensuing pancytopenia phases were solely handled in the outpatient clinic. Patients reported high satisfaction with home-based treatment, which had a positive influence on their ability to be involved in their treatment and be socially and physically active. No unexpected events occurred during the intervention. Overall, patients improved in all quality of life outcomes over time. Home-based intensive chemotherapy treatment was feasible and safe in this population. ClinicalTrials.gov identifier: NCT04904211.",
keywords = "Acute myeloid leukemia, Feasibility, Home-based, Intensive chemotherapy, Outpatient, Safety",
author = "N{\o}rskov, {Kristina Holmegaard} and Katrine Fridthjof and Peter Kampmann and Anne D{\"u}nweber and Andersen, {Christen Lykkegaard} and Toni Renaberg and Claudia Sch{\"o}llkopf and Ahmad, {Syed Azhar} and Katrine Schou and Jensen, {Cecilie Fremming} and Peter M{\o}ller and Lundholm, {Birgitte Wolf} and Claus Marcher and Lene Jepsen and {\O}rntoft, {Anne Katrine} and Ommen, {Hans Beier} and Lotte Andersen and Anni Behrentzs and Hasselgren, {Connie Fruergaard} and Marianne Severinsen and Grand, {Mia Klinten} and Mary Jarden and Tom M{\o}ller and Lars Kjeldsen",
note = "Copyright {\textcopyright} 2021 Elsevier Ltd. All rights reserved.",
year = "2022",
month = jan,
doi = "10.1016/j.leukres.2021.106756",
language = "English",
volume = "112",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Pergamon",

}

RIS

TY - JOUR

T1 - A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia

AU - Nørskov, Kristina Holmegaard

AU - Fridthjof, Katrine

AU - Kampmann, Peter

AU - Dünweber, Anne

AU - Andersen, Christen Lykkegaard

AU - Renaberg, Toni

AU - Schöllkopf, Claudia

AU - Ahmad, Syed Azhar

AU - Schou, Katrine

AU - Jensen, Cecilie Fremming

AU - Møller, Peter

AU - Lundholm, Birgitte Wolf

AU - Marcher, Claus

AU - Jepsen, Lene

AU - Ørntoft, Anne Katrine

AU - Ommen, Hans Beier

AU - Andersen, Lotte

AU - Behrentzs, Anni

AU - Hasselgren, Connie Fruergaard

AU - Severinsen, Marianne

AU - Grand, Mia Klinten

AU - Jarden, Mary

AU - Møller, Tom

AU - Kjeldsen, Lars

N1 - Copyright © 2021 Elsevier Ltd. All rights reserved.

PY - 2022/1

Y1 - 2022/1

N2 - Technological advances have made it possible to offer home-based chemotherapy to patients without health care professionals being present. Prior studies on effects of home-based treatment lack inclusion of patients with hematologic malignancies. We present data from a multicenter single-arm feasibility and safety study of home-based intensive chemotherapy in patients with newly diagnosed acute myeloid leukemia and their quality of life and psychological wellbeing. This national study included patients from six sites in Denmark who received intensive chemotherapy on programmed CADD Solis infusion pumps through a central venous catheter and were also managed as outpatients during treatment-induced pancytopenia. Data are presented from 104 patients, receiving 272 treatments with 1.096 (mean 4.57, SD 3.0) home infusion days out of 1.644 treatment days (67 %). Sixty-two of 168 (36.9 %) reinduction and consolidation treatment cycles ensuing pancytopenia phases were solely handled in the outpatient clinic. Patients reported high satisfaction with home-based treatment, which had a positive influence on their ability to be involved in their treatment and be socially and physically active. No unexpected events occurred during the intervention. Overall, patients improved in all quality of life outcomes over time. Home-based intensive chemotherapy treatment was feasible and safe in this population. ClinicalTrials.gov identifier: NCT04904211.

AB - Technological advances have made it possible to offer home-based chemotherapy to patients without health care professionals being present. Prior studies on effects of home-based treatment lack inclusion of patients with hematologic malignancies. We present data from a multicenter single-arm feasibility and safety study of home-based intensive chemotherapy in patients with newly diagnosed acute myeloid leukemia and their quality of life and psychological wellbeing. This national study included patients from six sites in Denmark who received intensive chemotherapy on programmed CADD Solis infusion pumps through a central venous catheter and were also managed as outpatients during treatment-induced pancytopenia. Data are presented from 104 patients, receiving 272 treatments with 1.096 (mean 4.57, SD 3.0) home infusion days out of 1.644 treatment days (67 %). Sixty-two of 168 (36.9 %) reinduction and consolidation treatment cycles ensuing pancytopenia phases were solely handled in the outpatient clinic. Patients reported high satisfaction with home-based treatment, which had a positive influence on their ability to be involved in their treatment and be socially and physically active. No unexpected events occurred during the intervention. Overall, patients improved in all quality of life outcomes over time. Home-based intensive chemotherapy treatment was feasible and safe in this population. ClinicalTrials.gov identifier: NCT04904211.

KW - Acute myeloid leukemia

KW - Feasibility

KW - Home-based

KW - Intensive chemotherapy

KW - Outpatient

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=85119927292&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2021.106756

DO - 10.1016/j.leukres.2021.106756

M3 - Journal article

C2 - 34839055

VL - 112

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

M1 - 106756

ER -

ID: 69452051